Cargando…

Antibody signatures in patients with histopathologically defined multiple sclerosis patterns

Early active multiple sclerosis (MS) lesions can be classified histologically into three main immunopathological patterns of demyelination (patterns I–III), which suggest pathogenic heterogeneity and may predict therapy response. Patterns I and II show signs of immune-mediated demyelination, but onl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stork, Lidia, Ellenberger, David, Ruprecht, Klemens, Reindl, Markus, Beißbarth, Tim, Friede, Tim, Kümpfel, Tania, Gerdes, Lisa A., Gloth, Mareike, Liman, Thomas, Paul, Friedemann, Brück, Wolfgang, Metz, Imke
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035238/ https://www.ncbi.nlm.nih.gov/pubmed/31950335 http://dx.doi.org/10.1007/s00401-019-02120-x

Ejemplares similares

Serum peptide reactivities may distinguish neuromyelitis optica subgroups and multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)

Neurofilament light chains in serum as biomarkers of axonal damage in early MS lesions: a histological–serological correlative study
por: Dietmann, Anne-Sophie, et al.
Publicado: (2022)

CNS inflammation after natalizumab therapy for multiple sclerosis: A retrospective histopathological and CSF cohort study
por: Häusler, Darius, et al.
Publicado: (2021)

Autoantibodies to MOG in a distinct subgroup of adult multiple sclerosis
por: Spadaro, Melania, et al.
Publicado: (2016)

Pathology of immune reconstitution inflammatory syndrome in multiple sclerosis with natalizumab-associated progressive multifocal leukoencephalopathy
por: Metz, Imke, et al.
Publicado: (2011)

Defining distinct features of anti-MOG antibody associated central nervous system demyelination
por: Weber, Martin S., et al.
Publicado: (2018)

Reporting FDR analogous confidence intervals for the log fold change of differentially expressed genes
por: Jung, Klaus, et al.
Publicado: (2011)

Disseminated necrotizing leukoencephalopathy eight months after alemtuzumab treatment for multiple sclerosis
por: Metz, Imke, et al.
Publicado: (2016)

Chances and challenges of a long-term data repository in multiple sclerosis: 20th birthday of the German MS registry
por: Ohle, Lisa-Marie, et al.
Publicado: (2021)

Rescue therapy with alemtuzumab in B cell/antibody-mediated multiple sclerosis
por: Akgün, Katja, et al.
Publicado: (2018)

Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod
por: Sinnecker, Tim, et al.
Publicado: (2016)

Optical coherence tomography in myelin-oligodendrocyte-glycoprotein antibody-seropositive patients: a longitudinal study
por: Oertel, Frederike C., et al.
Publicado: (2019)

Microglial nodules in early multiple sclerosis white matter are associated with degenerating axons
por: Singh, Shailender, et al.
Publicado: (2013)

Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration
por: Bozin, Ivan, et al.
Publicado: (2015)

Does Nrf2 help nerves to survive?
por: Ruprecht, Klemens, et al.
Publicado: (2015)

7 Tesla MRI of Balo's concentric sclerosis versus multiple sclerosis lesions
por: Behrens, Janina R., et al.
Publicado: (2018)

Increased interleukin-27 cytokine expression in the central nervous system of multiple sclerosis patients
por: Lalive, Patrice H., et al.
Publicado: (2017)

Cell type-specific Nrf2 expression in multiple sclerosis lesions
por: Licht-Mayer, Simon, et al.
Publicado: (2015)

Histopathology and clinical course of MOG-antibody-associated encephalomyelitis
por: Spadaro, Melania, et al.
Publicado: (2015)

MRI phase changes in multiple sclerosis vs neuromyelitis optica lesions at 7T
por: Sinnecker, Tim, et al.
Publicado: (2016)

Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis
por: Kaufhold, Falko, et al.
Publicado: (2013)

Correction: Optic Neuritis Is Associated with Inner Nuclear Layer Thickening and Microcystic Macular Edema Independently of Multiple Sclerosis
por: Kaufhold, Falko, et al.
Publicado: (2013)

Relations of low contrast visual acuity, quality of life and multiple sclerosis functional composite: a cross-sectional analysis
por: Schinzel, Johann, et al.
Publicado: (2014)

Multiple sclerosis and subclinical neuropathology in healthy individuals with familial risk: A scoping review of MRI studies
por: Mortazavi, Matin, et al.
Publicado: (2021)

Delayed diagnosis of extraovarian teratoma in relapsing anti-NMDA receptor encephalitis
por: Kümpfel, Tania, et al.
Publicado: (2016)

Evaluation of the ‘ring sign’ and the ‘core sign’ as a magnetic resonance imaging marker of disease activity and progression in clinically isolated syndrome and early multiple sclerosis
por: Blindenbacher, Nelly, et al.
Publicado: (2020)

Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis
por: Romanello, Amy, et al.
Publicado: (2022)

DNA methylation signatures of monozygotic twins clinically discordant for multiple sclerosis
por: Souren, Nicole Y., et al.
Publicado: (2019)

Dimethyl fumarate impairs differentiated B cells and fosters central nervous system integrity in treatment of multiple sclerosis
por: Traub, Jan, et al.
Publicado: (2019)

Standardization of T1w/T2w Ratio Improves Detection of Tissue Damage in Multiple Sclerosis
por: Cooper, Graham, et al.
Publicado: (2019)

Plasma lipidomics of monozygotic twins discordant for multiple sclerosis
por: Penkert, Horst, et al.
Publicado: (2020)

Glial Cells Express Nuclear Nrf2 After Fumarate Treatment for Multiple Sclerosis and Psoriasis
por: Metz, Imke, et al.
Publicado: (2015)

Central role of Th2/Tc2 lymphocytes in pattern II multiple sclerosis lesions
por: Planas, Raquel, et al.
Publicado: (2015)

CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
por: Gerdes, Lisa Ann, et al.
Publicado: (2016)

Development of oral immunomodulatory agents in the management of multiple sclerosis
por: Nicholas, Richard, et al.
Publicado: (2011)

MOG-expressing teratoma followed by MOG-IgG-positive optic neuritis
por: Wildemann, Brigitte, et al.
Publicado: (2020)

Explorative study of emerging blood biomarkers in progressive multiple sclerosis (EmBioProMS): Design of a prospective observational multicentre pilot study
por: Abdelhak, Ahmed, et al.
Publicado: (2020)

Patient-reported outcomes and survival in multiple sclerosis: A 10-year retrospective cohort study using the Multiple Sclerosis Impact Scale–29
por: Raffel, Joel, et al.
Publicado: (2017)

Accumulation and therapeutic modulation of 6-sulfo LacNAc(+) dendritic cells in multiple sclerosis
por: Thomas, Katja, et al.
Publicado: (2014)

Detailed Characterization of T Cell Receptor Repertoires in Multiple Sclerosis Brain Lesions
por: Planas, Raquel, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h3pf0ajjasvh4o9ju8brbekaap